Changchun High-Tech Industry Group Co

Changchun High-Tech Industry Group Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Changchun High-Tech Industry Group Co (000661.SZ) as of Nov 19, 2026 is -903.78 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 35.74 % — a change of -2,628.94% (lower).

FCF Conversion

-903.78 %

YoY

-2,628.94%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Changchun High-Tech Industry Group Co is 2025 -903.78 % . FCF Conversion Rate (FCF/EBITDA) of Changchun High-Tech Industry Group Co was 2024 35.74 % . It decreases by -2,628.94% lower compared to the previous year.

The Changchun High-Tech Industry Group Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
19.72 CNY
Jan 1, 2019
61.40 CNY
Jan 1, 2020
0.46 CNY
Jan 1, 2021
29.30 CNY
Jan 1, 2022
17.76 CNY
Jan 1, 2023
66.51 CNY
Jan 1, 2024
35.74 CNY
Jan 1, 2025
-903.78 CNY
The Changchun High-Tech Industry Group Co FCF Conversion history
YEARFCF ConversionYoY
-903.78 %-2,628.94%
35.74 %-46.27%
66.51 %+274.61%
17.76 %-39.39%
29.30 %+6,328.73%
0.46 %-99.26%
61.40 %+211.33%
19.72 %-12.93%
22.65 %-10.58%
25.33 %-82.05%
141.12 %+152.18%
55.96 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Changchun High-Tech Industry Group Co Stock analysis

What does Changchun High-Tech Industry Group Co do? Changchun High & New Technology Industries (Group), Inc. generates revenue through the research, development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. Key products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines, and rabies vaccines for human use. The company also derives income from real estate development and property management services. Its primary market is domestic, serving customers within China who require pharmaceutical solutions and real estate services. The firm's biopharmaceutical segment focuses on innovative treatments such as growth hormone therapies and vaccines, targeting healthcare providers and consumers seeking advanced medical solutions. Real estate activities involve developing and managing properties, catering to residential and commercial clients in the domestic market. All operations are conducted within China, with no international expansion mentioned in the business description. Changchun High & New Technology Industries (Group), Inc. leverages its 8,841 full-time employees to support both pharmaceutical and real estate divisions. The company's product portfolio emphasizes high-demand medical treatments, including injectable growth hormones and vaccines, which are sold to domestic healthcare institutions and end-users. Real estate services complement the core business by providing additional revenue streams through property management and development. Changchun High-Tech Industry Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Changchun High-Tech Industry Group Co stock

FCF Conversion Rate (FCF/EBITDA) of Changchun High-Tech Industry Group Co is -903.78 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Changchun High-Tech Industry Group Co changed from 35.74 % to -903.78 %, representing a -2,628.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Changchun High-Tech Industry Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Changchun High-Tech Industry Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Changchun High-Tech Industry Group Co

All Key Metrics — Changchun High-Tech Industry Group Co